Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis

The aim of this study was to assess the effect of Adalimumab on different immune parameters in patients with RA. Adalimumab was administered (40 mg every other week for 26 weeks) to eight patients with RA that were refractory to conventional drug therapy. Peripheral blood samples were obtained at da...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Vigna-Pérez, M, Abud-Mendoza, C, Portillo-Salazar, H, Alvarado-Sánchez, B, Cuevas-Orta, E, Moreno-Valdés, R, Baranda, L, Paredes-Saharopulos, O, González-Amaro, R
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2005
Gaiak:
Clinical Studies
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1809428/
https://ncbi.nlm.nih.gov/pubmed/15996202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2005.02859.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak